最后更新: 2026年4月29日
Female urinary retention is a rare condition compared to males — literature shows an incidence ratio of female to male as low as 1:13. The reason is that women do not have a prostate gland, which is the most common cause of bladder outlet obstruction in aging men. However, when acute urinary retention (AUR) does occur in a female, it presents a complex diagnostic and management challenge even for experienced physicians.
- 曼谷医院泌尿外科中心 泰国 在线预订 02-310-3009 bhquro@bdms.co.th
- 春武里府斯里拉查(Samitivej Sriracha)医院 088-022-1445

The etiology of female urinary retention is almost always multifactorial, requiring careful step-by-step assessment. I categorize the management into two clinical episodes.

Two clinical episodes of female urinary retention
- Acute episode — First presentation or symptoms present for less than 6 weeks. This is treated as a potentially reversible condition, and the priority is identifying and correcting the underlying cause. Common acute triggers include the postpartum period and urological anti-incontinence surgery.
- Chronic episode — Urinary retention that persists even after correctable causes have been addressed. Causes are divided into:
- Bladder causes — neurogenic bladder, underactive detrusor
- Bladder outlet obstruction — gynecological tumors, urethral tumors, or pregnancy

The immediate management for AUR in any patient is bladder decompression. When the bladder is overdistended beyond its functional limit, the surrounding nerve fibers become injured and require a period of rest to recover their contractile function.
Step-by-step management of female AUR
- Immediate bladder decompression via urethral catheterization or clean intermittent catheterization (CIC)
- Identify and correct the underlying etiology
- Continue bladder decompression for 1–14 days to allow bladder recovery, then trial of voiding
- If voiding trial succeeds, continue monitoring with residual urine measurement. If retention persists, reassess the clinical situation and continue bladder decompression

Published data shows a 92.6% success rate after correction of the underlying etiology of female AUR, so this is a manageable condition with the right specialist approach.
你可以访问我的 官方主页在这里.
Frequently Asked Questions About Acute Urinary Retention in Females
Why is acute urinary retention less common in women than men?
Women do not have a prostate gland, which is the most common cause of bladder outlet obstruction in aging men. The female urethra is also shorter and wider, making mechanical obstruction less likely. Literature shows a female-to-male incidence ratio of approximately 1:13 for acute urinary retention. However, when it does occur in women, the etiology is typically complex and multifactorial, requiring thorough specialist evaluation.
What are the most common causes of acute urinary retention in women?
Common acute triggers include the postpartum period (after childbirth) and complications following urological anti-incontinence surgery. Chronic causes include neurogenic bladder dysfunction, underactive detrusor (bladder muscle weakness), gynecological or urethral tumors causing outlet obstruction, and pregnancy. Since causes are often multifactorial, a systematic diagnostic workup by a urologist is essential to identify all contributing factors before initiating treatment.
What is the treatment for acute urinary retention in women?
The immediate treatment is bladder decompression via urethral catheterization or clean intermittent catheterization, which allows the overdistended bladder to rest and recover. The underlying etiology is identified and corrected simultaneously. After 1–14 days of decompression, a voiding trial is performed. Published data shows a 92.6% success rate after well-corrected etiology. If the voiding trial fails, bladder decompression is continued and the clinical situation is reassessed by a specialist.
If you or a family member is experiencing difficulty urinating or has been diagnosed with female urinary retention, Dr. Soarawee Weerasopone offers specialist consultations at Bangkok Hospital Headquarters. 预约咨询.
**免责声明:** 本内容由曼谷医院总院的认证泌尿科医生 Soarawee Weerasopone 医生撰写和审阅。本内容仅用于教育目的,不构成医疗建议。在开始任何医疗治疗前,请务必咨询合格的医疗专业人士。.
医学撰写与审阅: 素瓦瑞·维拉宋蓬医生(Pom医生)— 曼谷医院总部认证泌尿科医生。 国际学者:贝勒医学院(美国)· 顺天堂大学(日本)· 长庚纪念医院(台湾)。.

素瓦拉维·维拉索蓬医生(Pom 医生)是曼谷医院总部的注册泌尿科医生,专长于男性健康、机器人手术(达芬奇手术系统)和肾结石治疗。他曾在贝勒医学院(美国)、顺天堂大学医院(日本)和长庚纪念医院(台湾)完成国际深造。本网站所有医疗内容均由素瓦拉维医生根据其临床经验和国际培训撰写和审阅。.

